Impact of variant of uncertain significance in breast cancer multigene germline panel testing on patient decision-making

被引：0

作者：

Carr, Azadeh ^{[1
]}

Traudt, Elizabeth ^{[1
]}

Geurts, Jennifer ^{[1
]}

Kong, Amanda ^{[1
]}

机构：

[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

404347

引用

页码：481 / 482

页数：2

共 50 条

[21] Economic impact of multigene panel testing for hereditary breast and ovarian cancer
Byfield, Stacey Dacosta
Wei, Helen
DuCharme, Mary
Lancaster, Johnathan M.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (03) : 207 - 217
[22] Integration of germline multigene panel testing into breast and gynecologic oncology clinics
Tejada, Mariella
Hou, June YiJuan
Crew, Katherine D.
Accordino, Melissa Kate
Kalinsky, Kevin
Hershman, Dawn L.
Tergas, Ana Isabel
St Clair, Caryn
Wright, Jason Dennis
Trivedi, Meghna S.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
[23] Patient preferences of decision-making in the context of genetic testing for breast cancer risk
Helmes, AW
Bowen, DJ
Bengel, J
GENETICS IN MEDICINE, 2002, 4 (03) : 150 - 157
[24] Germline multigene panel testing revealed aBRCA2pathogenic variant in a patient with suspected Lynch syndrome
Yoshihama, Tomoko
Hirasawa, Akira
Sugano, Kokichi
Yoshida, Teruhiko
Ushiama, Mineko
Ueki, Arisa
Akahane, Tomoko
Nanki, Yoshiko
Sakai, Kensuke
Makabe, Takeshi
Yamagami, Wataru
Susumu, Nobuyuki
Kameyama, Kaori
Kosaki, Kenjiro
Aoki, Daisuke
INTERNATIONAL CANCER CONFERENCE JOURNAL, 2021, 10 (01) : 6 - 10
[25] Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
Tomoko Yoshihama
Akira Hirasawa
Kokichi Sugano
Teruhiko Yoshida
Mineko Ushiama
Arisa Ueki
Tomoko Akahane
Yoshiko Nanki
Kensuke Sakai
Takeshi Makabe
Wataru Yamagami
Nobuyuki Susumu
Kaori Kameyama
Kenjiro Kosaki
Daisuke Aoki
International Cancer Conference Journal, 2021, 10 : 6 - 10
[26] Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
Horton, Carolyn
Blanco, Kirsten
Lo, Min-Tzu
Speare, Virginia
LaDuca, Holly
Dolinsky, Jill S.
Kurian, Allison W.
JNCI CANCER SPECTRUM, 2022, 6 (02)
[27] Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
Kurian, Allison W.
Li, Yun
Hamilton, Ann S.
Ward, Kevin C.
Hawley, Sarah T.
Morrow, Monica
McLeod, M. Chandler
Jagsi, Reshma
Katz, Steven J.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (20) : 2232 - +
[28] Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
Lhotova, Klara
Stolarova, Lenka
Zemankova, Petra
Vocka, Michal
Janatova, Marketa
Borecka, Marianna
Cerna, Marta
Jelinkova, Sandra
Kral, Jan
Volkova, Zuzana
Urbanova, Marketa
Kleiblova, Petra
Machackova, Eva
Foretova, Lenka
Hazova, Jana
Vasickova, Petra
Lhota, Filip
Koudova, Monika
Cerna, Leona
Tavandzis, Spiros
Indrakova, Jana
Hruskova, Lucie
Kosarova, Marcela
Vrtel, Radek
Stranecky, Viktor
Kmoch, Stanislav
Zikan, Michal
Macurek, Libor
Kleibl, Zdenek
Soukupova, Jana
CANCERS, 2020, 12 (04)
[29] Patient satisfaction with decision-making for breast cancer therapy
Weiss, SM
Wengert, PA
Martinez, EM
Sewall, W
Kopp, E
ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (03) : 285 - 289
[30] Universal Germline Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision Making
Shelton, Charles
Nielsen, Sarah
Ruiz, Antonio
Shelton, Lauren
Freas, Karen
Poll, Sarah
Heald, Brandie
Pineda-Alvarez, Daniel
Esplin, Edward
Ellsworth, Rachel
Montgomery, Hannah
CANCER RESEARCH, 2024, 84 (09)

← 1 2 3 4 5 →